These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7566353)
41. p38 kinase is activated in the Alzheimer's disease brain. Hensley K; Floyd RA; Zheng NY; Nael R; Robinson KA; Nguyen X; Pye QN; Stewart CA; Geddes J; Markesbery WR; Patel E; Johnson GV; Bing G J Neurochem; 1999 May; 72(5):2053-8. PubMed ID: 10217284 [TBL] [Abstract][Full Text] [Related]
42. Effects of endogenous beta-amyloid overproduction on tau phosphorylation in cell culture. Wang ZF; Li HL; Li XC; Zhang Q; Tian Q; Wang Q; Xu H; Wang JZ J Neurochem; 2006 Aug; 98(4):1167-75. PubMed ID: 16762022 [TBL] [Abstract][Full Text] [Related]
43. Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic mice. Götz J; Nitsch RM Neuroreport; 2001 Jul; 12(9):2007-16. PubMed ID: 11435938 [TBL] [Abstract][Full Text] [Related]
44. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
45. Unilateral amyloid-beta25-35 injection into the rat amygdala increases the expressions of aberrant tau phosphorylation kinases. Huang J; Chen YJ; Bian WH; Yu J; Zhao YW; Liu XY Chin Med J (Engl); 2010 May; 123(10):1311-4. PubMed ID: 20529587 [TBL] [Abstract][Full Text] [Related]
47. Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes. Ksiezak-Reding H; He D; Gordon-Krajcer W; Kress Y; Lee S; Dickson DW Cell Motil Cytoskeleton; 2000 Nov; 47(3):236-52. PubMed ID: 11056524 [TBL] [Abstract][Full Text] [Related]
48. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
49. Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Sperber BR; Leight S; Goedert M; Lee VM Neurosci Lett; 1995 Sep; 197(2):149-53. PubMed ID: 8552282 [TBL] [Abstract][Full Text] [Related]
50. Protein kinase FA/glycogen synthase kinase-3 alpha after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer's disease brain. Yang SD; Yu JS; Shiah SG; Huang JJ J Neurochem; 1994 Oct; 63(4):1416-25. PubMed ID: 7931292 [TBL] [Abstract][Full Text] [Related]
51. Quantitative analysis of tau protein in paired helical filament preparations: implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer's disease. Wischik CM; Edwards PC; Lai RY; Gertz HN; Xuereb JH; Paykel ES; Brayne C; Huppert FA; Mukaetova-Ladinska EB; Mena R Neurobiol Aging; 1995; 16(3):409-17; discussion 418-31. PubMed ID: 7566350 [TBL] [Abstract][Full Text] [Related]
52. Protein kinase FA/GSK-3 phosphorylates tau on Ser235-Pro and Ser404-Pro that are abnormally phosphorylated in Alzheimer's disease brain. Yang SD; Song JS; Yu JS; Shiah SG J Neurochem; 1993 Nov; 61(5):1742-7. PubMed ID: 8228990 [TBL] [Abstract][Full Text] [Related]
53. Beta-amyloid and ionophore A23187 evoke tau hyperphosphorylation by distinct intracellular pathways: differential involvement of the calpain/protein kinase C system. Shea TB; Prabhakar S; Ekinci FJ J Neurosci Res; 1997 Sep; 49(6):759-68. PubMed ID: 9335263 [TBL] [Abstract][Full Text] [Related]
54. Induction of a specific tau Alzheimer epitope in SY-5Y neuroblastoma cells. Caillet-Boudin ML; Delacourte A Neuroreport; 1996 Dec; 8(1):307-10. PubMed ID: 9051801 [TBL] [Abstract][Full Text] [Related]
55. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173 [TBL] [Abstract][Full Text] [Related]
56. Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy. Congdon EE; Lin Y; Rajamohamedsait HB; Shamir DB; Krishnaswamy S; Rajamohamedsait WJ; Rasool S; Gonzalez V; Levenga J; Gu J; Hoeffer C; Sigurdsson EM Mol Neurodegener; 2016 Aug; 11(1):62. PubMed ID: 27578006 [TBL] [Abstract][Full Text] [Related]
57. Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study. Chin JY; Knowles RB; Schneider A; Drewes G; Mandelkow EM; Hyman BT J Neuropathol Exp Neurol; 2000 Nov; 59(11):966-71. PubMed ID: 11089574 [TBL] [Abstract][Full Text] [Related]
58. Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site. Brion JP; Hanger DP; Bruce MT; Couck AM; Flament-Durand J; Anderton BH Biochem J; 1991 Jan; 273(Pt 1)(Pt 1):127-33. PubMed ID: 1899184 [TBL] [Abstract][Full Text] [Related]
59. Hyperphosphorylation of Tau and filopodial retraction following microinjection of protein kinase C catalytic subunits. Cressman CM; Shea TB J Neurosci Res; 1995 Dec; 42(5):648-56. PubMed ID: 8600297 [TBL] [Abstract][Full Text] [Related]
60. Phosphorylation of microtubule-associated protein tau by Ca2+/calmodulin-dependent protein kinase II in its tubulin binding sites. Yamamoto H; Yamauchi E; Taniguchi H; Ono T; Miyamoto E Arch Biochem Biophys; 2002 Dec; 408(2):255-62. PubMed ID: 12464279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]